The Prognostic Values of Preoperative Tumor Volume and Tumor Diameter in T1N0 Papillary Thyroid Cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose The current TNM staging system for papillary thyroid cancer (PTC), which is based on tumor diameter, may not precisely reflect the true tumor burden. Therefore, we investigated whether preoperative tumor volume might more accurately reflect tumor burden and predict prognosis in patients with T1N0 PTC than preoperative tumor diameter. Materials and Methods We retrospectively reviewed data from 1,659 patients with T1N0 PTC, and after exclusion, a total of 1,081 patients were ultimately included. Tumor volume (V) was calculated for all patients using preoperative ultrasonography, and patients were grouped according to tumor diameter (T1a vs. T1b) and tumor volume (V1a vs. V1b). The recurrence-free survival (RFS) rates were then compared for these groups. Results The mean follow-up time was 66.12±28.75 months, and 97.2% of the cohort experienced RFS. The optimal volume cut-off was defined as 0.545 cm3. There were no differences in RFS rates between T1a/T1b groups (all ages) and V1a/V1b groups (< 45 years of age). However, 45-year-old patients in the V1b group had a significantly poorer RFS rate than those in the V1a group. These results were confirmed by multivariate analysis. Conclusion Our results indicate that preoperative tumor volume may be more useful for predicting prognosis than tumor diameter in 45-year-old patients with T1N0 PTC.
Abstract
Purpose The current TNM staging system for papillary thyroid cancer (PTC), which is based on tumor diameter, may not precisely reflect the true tumor burden. Therefore, we investigated whether preoperative tumor volume might more accurately reflect tumor burden and predict prognosis in patients with T1N0 PTC than preoperative tumor diameter. Materials and Methods We retrospectively reviewed data from 1,659 patients with T1N0 PTC, and after exclusion, a total of 1,081 patients were ultimately included. Tumor volume (V) was calculated for all patients using preoperative ultrasonography, and patients were grouped according to tumor diameter (T1a vs. T1b) and tumor volume (V1a vs. V1b). The recurrence-free survival (RFS) rates were then compared for these groups. Results The mean follow-up time was 66.12±28.75 months, and 97.2% of the cohort experienced RFS. The optimal volume cut-off was defined as 0.545 cm3. There were no differences in RFS rates between T1a/T1b groups (all ages) and V1a/V1b groups (< 45 years of age). However, 45-year-old patients in the V1b group had a significantly poorer RFS rate than those in the V1a group. These results were confirmed by multivariate analysis. Conclusion Our results indicate that preoperative tumor volume may be more useful for predicting prognosis than tumor diameter in 45-year-old patients with T1N0 PTC.
참고문헌 (18)
- Schlumberger MJ, "Papillary and follicular thyroid carcinoma", N Engl J Med, 338, pp.297~306 (1998)
- DeSantis CE, "Cancer treatment and survivorship statistics, 2014", CA Cancer J Clin, 64, pp.252~271 (2014)
- Enewold L, "Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005", Cancer Epidemiol Biomarkers Prev, 18, pp.784~791 (2009)
- Lee JH, "BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas", Pathology, 38, pp.201~204 (2006)
- Hall SF, "Increasing detection and increasing incidence in thyroid cancer", World J Surg, 33, pp.2567~2571 (2009)
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295, pp.2164~2167 (2006)
- Brito JP, "Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours", BMJ, 347, pp.f4706~ (2013)
- Ahn HS, "Korea's thyroid-cancer"epidemic" : screening and overdiagnosis", N Engl J Med, 371, pp.1765~1767 (2014)
- Edge SB, "AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual" (2010), Springer
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer", Thyroid, 26, pp.1~133 (2016)
- Tsai CH, "Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer", Thorac Cardiovasc Surg, 54, pp.537~543 (2006)
- Davis KS, "Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer", Head Neck, 38(Suppl 1), pp.E1613~E1617 (2016)
- Park KN, "Predictive value of estimated tumor volume measured by ultrasonography for occult central lymph node metastasis in papillary thyroid carcinoma", Ultrasound Med Biol, 41, pp.2849~2854 (2015)
- Anderson KL Jr, "T1a versus T1b differentiated thyroid cancers:do we need to make the distinction", Thyroid, 26, pp.1046~1052 (2016)
- Wang LY, "Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system", Surgery, 156, pp.1484~1489 (2014)
- Chereau N, "Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer", Langenbecks Arch Surg, 401, pp.223~230 (2016)
- Moon HJ, "Positive predictive value and interobserver variability of preoperative staging sonography for thyroid carcinoma", AJR Am J Roentgenol, 197, pp.W324~W330 (2011)
- Park JS, "Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC", UICC TNM classification system, 2009, pp.192, 66~72